Real-world Experience Within Standard NHS Use of Traztuzumab Deruxtecan As Late Line Therapy for Advanced HER-2-positive Breast Cancer

S. Graef,R. Kussaibati,K. Herring, L. Pallan,M. Jafri,M. Tsalic, D. Henderson, R. Thompson,D. Rea

Clinical Oncology（2023）

Cited 0|Views4

AI Read Science

Must-Reading Tree

Example

Generate MRT to find the research sequence of this paper

Chat Paper

Summary is being generated by the instructions you defined